This past week, NYSCF – Robertson Investigator Alumnae Kay Tye, PhD (2014; Salk Institute for Biological Sciences), Kristy Red-Horse, PhD (2015; Stanford University), and Vanessa Ruta,...
“My oldest son, Andrew, is a cancer survivor,” said Tony Coles, MD, PhD, CEO of Cerevel Therapeutics. “He was afflicted with non-Hodgkins lymphoma when he...
“We had the foundational tools we needed to move our research from academia to biotech,” remarked NYSCF – Robertson Investigator Alumnus Dr. Paul Tesar. “We had...
The Context: When a major heart artery is blocked, the oxygen-starved areas of the heart are kept healthy by smaller arteries called collateral arteries. Some people...
“Medicine shouldn’t be one size fits all,” National Institutes of Health (NIH) Director Dr. Francis Collins told the audience of the NYSCF Conference last week. “Think...
The heart is made of muscle, and for it to function properly, that muscle has to be strong and durable. A condition called left ventricular non-compaction...
Stem Cell research has unprecedented potential to improve treatment for and ultimately preventing heart disease due to the unique capability of stem cells for self-renewal, differentiation...
The expression of a single gene can directly convert heart muscle cells to cardiac pacemaker cells (i.e. SAN cells) both in an animal and a dish....
The New York Stem Cell Foundation (NYSCF) held its seventh annual spring public outreach event to bring together global experts on heart disease, bioethics, and stem...
NYSCF-Druckenmiler Fellow, Dr. Daylon James, had his research on endothelial differentiation and expansion published in Nature Biotechnology on January 17th. In this interview, Dr. James talks...
